NM_030777.4:c.1154C>G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_030777.4(SLC2A10):​c.1154C>G​(p.Ala385Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00708 in 1,614,230 control chromosomes in the GnomAD database, including 321 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 93 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 228 hom. )

Consequence

SLC2A10
NM_030777.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.0200
Variant links:
Genes affected
SLC2A10 (HGNC:13444): (solute carrier family 2 member 10) This gene encodes a member of the class III facilitative glucose transporter family. The encoded protein plays a role in regulation of glucose homeostasis. Mutations in this gene have been associated with arterial tortuosity syndrome.[provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024423003).
BP6
Variant 20-46726190-C-G is Benign according to our data. Variant chr20-46726190-C-G is described in ClinVar as [Benign]. Clinvar id is 139174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-46726190-C-G is described in Lovd as [Benign]. Variant chr20-46726190-C-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.055 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A10NM_030777.4 linkc.1154C>G p.Ala385Gly missense_variant Exon 2 of 5 ENST00000359271.4 NP_110404.1 O95528

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A10ENST00000359271.4 linkc.1154C>G p.Ala385Gly missense_variant Exon 2 of 5 1 NM_030777.4 ENSP00000352216.2 O95528

Frequencies

GnomAD3 genomes
AF:
0.0185
AC:
2824
AN:
152276
Hom.:
92
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0569
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00575
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0556
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.0124
GnomAD3 exomes
AF:
0.0114
AC:
2858
AN:
251270
Hom.:
81
AF XY:
0.0125
AC XY:
1695
AN XY:
135872
show subpopulations
Gnomad AFR exome
AF:
0.0536
Gnomad AMR exome
AF:
0.00413
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.0542
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00127
Gnomad OTH exome
AF:
0.00570
GnomAD4 exome
AF:
0.00588
AC:
8594
AN:
1461836
Hom.:
228
Cov.:
33
AF XY:
0.00706
AC XY:
5135
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.0568
Gnomad4 AMR exome
AF:
0.00445
Gnomad4 ASJ exome
AF:
0.000306
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.0509
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00141
Gnomad4 OTH exome
AF:
0.00798
GnomAD4 genome
AF:
0.0186
AC:
2833
AN:
152394
Hom.:
93
Cov.:
33
AF XY:
0.0188
AC XY:
1400
AN XY:
74526
show subpopulations
Gnomad4 AFR
AF:
0.0569
Gnomad4 AMR
AF:
0.00568
Gnomad4 ASJ
AF:
0.000864
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0561
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00110
Gnomad4 OTH
AF:
0.0123
Alfa
AF:
0.00571
Hom.:
5
Bravo
AF:
0.0195
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.0495
AC:
218
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.0134
AC:
1626
Asia WGS
AF:
0.0270
AC:
95
AN:
3478
EpiCase
AF:
0.00136
EpiControl
AF:
0.00154

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Arterial tortuosity syndrome Benign:5
Feb 04, 2014
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 19, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 30, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 15, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 19, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: SLC2A10 c.1154C>G (p.Ala385Gly) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.011 in 251270 control chromosomes in the gnomAD database, including 81 homozygotes. The observed variant frequency is approximately 7.0 fold of the estimated maximal expected allele frequency for a pathogenic variant in SLC2A10 causing Aortopathy phenotype (0.0016), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1154C>G in individuals affected with Aortopathy and no experimental evidence demonstrating its impact on protein function have been reported. Co-occurrences with other pathogenic variant(s) have been reported at our laboratory (FBN1 c.349C>T, p.Q117*), providing supporting evidence for a benign role. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -

Familial thoracic aortic aneurysm and aortic dissection Benign:2
Apr 02, 2015
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nov 17, 2022
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
1.3
DANN
Benign
0.69
DEOGEN2
Benign
0.10
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.30
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.55
N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.11
Sift
Benign
0.41
T
Sift4G
Benign
0.42
T
Polyphen
0.0
B
Vest4
0.033
MPC
0.065
ClinPred
0.00097
T
GERP RS
-1.7
Varity_R
0.027
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs79849424; hg19: chr20-45354829; API